28th Feb 2024 12:51
(Sharecast News) - Digital health company Trellus Health announced a significant agreement with a major US health plan on Wednesday, targeting inflammatory bowel disease (IBD) management.
Read more17th Feb 2023 16:24
(Sharecast News) - Trellus Health announced the launch of a direct-to-consumer (D2C) offering for people living with Irritable Bowel Syndrome (IBS) on Friday.
Read more20th Dec 2022 15:15
(Sharecast News) - Trellus Health said in an update on Tuesday that for the 2022 period, it was expecting to report that "modest" revenue and an EBITDA loss in line with expectations.
Read more19th Oct 2022 13:39
(Sharecast News) - Trellus Health announced on Wednesday that the 'Trellus Resilience Training and Self-Management Solution' for inflammatory bowel disease was now available on GI OnDemand, a gastroenterology-focussed multidisciplinary virtual integrated care platform.
Read more17th Oct 2022 14:03
(Sharecast News) - Healthcare self-management technology company Trellus Health has signed two contracts with the Mount Sinai Health System, it announced on Monday, to provide access to its resilience training and self-management programme for inflammatory bowel disease.
Read more1st Aug 2022 13:38
(Sharecast News) - Connected health technology developer Trellus Health announced the appointment of Stephen 'Steve' Young as its interim chief financial officer on Monday, with immediate effect.
Read more28th Feb 2022 14:30
(Sharecast News) - Connected health platform operator Trellus Health announced the launch of its direct-to-consumer offering in the New York tri-state area on Monday, for people living with Crohn's disease and ulcerative colitis.
Read more17th Jan 2022 12:48
(Sharecast News) - Connected health management technology developer Trellus Health said on Monday that clinical research conducted by its co-founders Laurie Keefer and Marla Dubinsky had associated the 'GRITT', or 'Gaining Resilience Through Transitions'. methodology with significantly lower healthcare utilisation, corticosteroid and opioid use in patients with inflammatory bowel disease (IBD).
Read more